Home › Funds › Papamarkou Wellner Asset Management inc. › GILD
Papamarkou Wellner Asset Management inc. position in GILD
GILEAD SCIENCES INC · Health Care
Papamarkou Wellner Asset Management inc. reported holding 14,326 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$2.1M, representing 1.17% of its reported portfolio and ranking #23 among its reported holdings. Papamarkou Wellner Asset Management inc. has disclosed GILD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Papamarkou Wellner Asset Management inc.'s GILD position evolved
Papamarkou Wellner Asset Management inc. first disclosed a stake in GILD in Q4 2024 at 16,567 shares (US$1.5M). The position peaked in Q1 2026 at 15,891 shares, worth US$2.2M. Across 8 filings, Papamarkou Wellner Asset Management inc. increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 14,326 shares valued at US$2.1M — a reduction of -1,565 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 16.57K | $1.53M | New |
| Q1 2025 | 16.10K | $1.80M | Reduce |
| Q2 2025 | 15.77K | $1.75M | Reduce |
| Q3 2025 | 15.67K | $1.74M | Reduce |
| Q4 2025 | 15.72K | $1.93M | Hold |
| Q1 2026 | 15.89K | $2.21M | Add |
| Q2 2026 | 15.89K | $2.21M | Hold |
| Q3 2026 | 14.33K | $2.14M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- BlackRock Inc 125.25M sh · $18.67B · Q3 2026
- Fidelity Management & Research (FMR) 58.27M sh · $8.68B · Q3 2026
- Invesco Ltd 38.66M sh · $5.76B · Q3 2026
- Capital World Investors 35.93M sh · $5.36B · Q3 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Capital Research Global Investors 23.98M sh · $3.57B · Q3 2026
- DODGE & COX 21.80M sh · $3.25B · Q3 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- MFS Investment Management 11.46M sh · $1.77B · Q3 2026
- Amundi US 11.26M sh · $1.68B · Q3 2026
- Legal & General Investment Management America 10.40M sh · $1.55B · Q3 2026
More on Papamarkou Wellner Asset Management inc.
FAQ
How long has Papamarkou Wellner Asset Management inc. held GILD?
Papamarkou Wellner Asset Management inc. has disclosed GILD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Papamarkou Wellner Asset Management inc.'s current position in GILD?
As of Q3 2026, Papamarkou Wellner Asset Management inc. holds 14.33K shares of GILD (GILEAD SCIENCES INC), valued at $2.14M, representing 1.17% of its reported portfolio and ranking #23.
Has Papamarkou Wellner Asset Management inc. been buying or selling GILD?
In the latest 13F filing (Q3 2026), Papamarkou Wellner Asset Management inc. reduced its position in GILD. The position peaked in Q1 2026 at 15.89K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.